医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

KCI Medical India Honored as One of Economic Times’ Best Healthcare Brands of 2019

2019年06月27日 AM11:30
このエントリーをはてなブックマークに追加


 

SAN ANTONIO

KCI, an Acelity Company, today announced that the Company has been recognized in India as one of the Economic Times’ Best Healthcare Brands of 2019. This prestigious award honors brands with robust growth, brand excellence, high customer satisfaction and a commitment to innovation across the healthcare sector.

Data was collected through an 11-city survey, comprised of more than 9,000 consumers, patients, healthcare professionals and hospital stakeholders to build a list of brands who symbolize quality, trust and reliability in the Indian healthcare market. The winners were chosen after extensive quantitative and qualitative analyses of the data collected and overall performance of the companies. This year marks the Economic Times’ third edition of this initiative.

“We are honored to have been recognized as one of the Best Healthcare Brands of 2019 in India by the Economic Times,” said R. Andrew Eckert, Chief Executive Officer, KCI. “As a company, we are committed to increasing patient access to our advanced wound care solutions around the globe. We are pleased with the continued success of our operations in India and look forward to reinforcing our position as a company that healthcare providers and their patients can turn to for their advanced wound care needs.”

“As the healthcare sector in India continues to strengthen, establishing an even stronger foothold in the region has been a keen focus for us,” said Sanjeev Kumar Sawhney, Regional Vice President and General Manager, India, KCI. “Since establishing operations in India in 2012, we have been tirelessly working to ensure clinicians and patients across the country have access to our products when they need them most. This award is a testament to the hard work KCI Medical India has put in over the last few years and we hope to continue the trend of growth, high customer satisfaction and unwavering innovation in the market.”

About KCI, an Acelity Company

KCI, an Acelity Company, is a well trusted brand in advanced wound care. We are a leader in negative pressure wound therapy, providing solutions for both wound healing and surgical management. Our product offerings are available in more than 90 countries and deliver value through solutions that speed healing. KCI is a leader in quality, safety and customer experience and is committed to advancing the science of healing. Headquartered in San Antonio, Texas, KCI employs approximately 4,500 people worldwide.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190626005638/en/

CONTACT

Maggie Fairchild

Corporate Communications

Phone: +1-210-330-2666

Email: maggie.fairchild@acelity.com

Caleb Moore

Investor Relations

Phone: +1 210-255-6433

Email: caleb.moore@acelity.com

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表